Yu-Hui Wang

1.6k total citations
32 papers, 1.1k citations indexed

About

Yu-Hui Wang is a scholar working on Oncology, Management of Technology and Innovation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu-Hui Wang has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Management of Technology and Innovation and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu-Hui Wang's work include Intellectual Property and Patents (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yu-Hui Wang is often cited by papers focused on Intellectual Property and Patents (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Yu-Hui Wang collaborates with scholars based in Taiwan, United States and China. Yu-Hui Wang's co-authors include Amy J.C. Trappey, Ching‐Hung Lee, Chien‐Feng Li, Hsuan-Ying Huang, Shau-Hsuan Li, Yow-Ling Shiue, Shih-Chen Yu, Fu-Min Fang, Wen-Ren Wu and Li‐Tzong Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Clinical Cancer Research.

In The Last Decade

Yu-Hui Wang

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Hui Wang Taiwan	19	438	288	247	211	109	32	1.1k
Shinichi Fukushige Japan	29	1.3k 3.0×	580 2.0×	421 1.7×	110 0.5×	93 0.9×	137	2.5k
Yu‐Cheng Lee Taiwan	29	575 1.3×	343 1.2×	214 0.9×	165 0.8×	15 0.1×	92	2.4k
Hsiang‐Cheng Chi Taiwan	27	1.1k 2.5×	263 0.9×	818 3.3×	159 0.8×	45 0.4×	62	1.9k
Juliang Zhang China	29	418 1.0×	230 0.8×	185 0.7×	91 0.4×	21 0.2×	135	2.3k
Chi‐Cheng Huang Taiwan	21	345 0.8×	258 0.9×	201 0.8×	165 0.8×	11 0.1×	102	1.6k
Bingli Wu China	18	874 2.0×	231 0.8×	489 2.0×	171 0.8×	30 0.3×	52	1.3k
Cheng‐Nan Chen Taiwan	22	400 0.9×	151 0.5×	146 0.6×	70 0.3×	14 0.1×	74	1.5k
Giuseppe Russo Italy	21	463 1.1×	247 0.9×	167 0.7×	98 0.5×	12 0.1×	105	1.7k
Chunyan Duan China	26	504 1.2×	139 0.5×	193 0.8×	162 0.8×	13 0.1×	75	2.0k

Countries citing papers authored by Yu-Hui Wang

Since Specialization

Citations

This map shows the geographic impact of Yu-Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Hui Wang more than expected).

Fields of papers citing papers by Yu-Hui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Hui Wang. The network helps show where Yu-Hui Wang may publish in the future.

Co-authorship network of co-authors of Yu-Hui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Hui Wang. A scholar is included among the top collaborators of Yu-Hui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Hui Wang. Yu-Hui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yu-Hui. (2024). Exploring Technology-Driven Technology Roadmaps (TRM) for Wearable Biosensors in Healthcare. IRBM. 45(3). 100835–100835. 1 indexed citations

Wang, Guihua, Jie Long, Yuan Gao, et al.. (2021). Author Correction: SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis. Nature Cell Biology. 23(6). 676–676. 4 indexed citations

Shi, Ruoshi, Nikolina Radulovich, Christine Ng, et al.. (2019). Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(5). 1162–1174. 204 indexed citations

Wang, Guihua, Jie Long, Yuan Gao, et al.. (2019). SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis. Nature Cell Biology. 21(2). 214–225. 143 indexed citations

Wang, Yu-Hui, et al.. (2017). Explore technology innovation and intelligence for IoT (Internet of Things) based eyewear technology. Technological Forecasting and Social Change. 127. 281–290. 32 indexed citations

Wang, Wei‐Jan, Chien‐Feng Li, Yu‐Yi Chu, et al.. (2016). Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder. Clinical Cancer Research. 23(2). 503–513. 51 indexed citations

Wang, Yu-Hui, Ching‐Hung Lee, & Amy J.C. Trappey. (2016). Modularized design-oriented systematic inventive thinking approach supporting collaborative service innovations. Advanced Engineering Informatics. 33. 300–313. 35 indexed citations

Wang, Yu-Hui, et al.. (2016). Applying Patent-Based Fuzzy Quality Function Deployment to Explore Prospective VoLTE Technologies. International Journal of Fuzzy Systems. 18(3). 424–435. 7 indexed citations

Li, Chien‐Feng, Fu-Min Fang, Hsing-Jien Kung, et al.. (2014). Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance. Oncotarget. 5(22). 11428–11441. 19 indexed citations

10.

Li, Chien‐Feng, Fu-Min Fang, Jui Lan, et al.. (2014). AMACR Amplification in Myxofibrosarcomas: A Mechanism of Overexpression That Promotes Cell Proliferation with Therapeutic Relevance. Clinical Cancer Research. 20(23). 6141–6152. 34 indexed citations

11.

Huang, Hsuan-Ying, Wen-Ren Wu, Yu-Hui Wang, et al.. (2013). ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance. Clinical Cancer Research. 19(11). 2861–2872. 118 indexed citations

12.

Li, Chien‐Feng, Li‐Tzong Chen, Ching-Yih Lin, et al.. (2013). Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma. 5(1-2). 31–38. 2 indexed citations

13.

Trappey, Amy J.C., Yu-Hui Wang, Charles V. Trappey, Chunyi Wu, & Dong Lin. (2013). Ontology-based Patent Licensing and Litigation Strategic Knowledge System for the Light Emitting Diode Industry. SHILAP Revista de lepidopterología. 3(3). 155–167. 2 indexed citations

14.

Lin, Ching-Yih, Yu-Feng Tian, Li-Ching Wu, et al.. (2012). Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation. Journal of Clinical Pathology. 65(8). 687–692. 22 indexed citations

15.

Wu, Li-Ching, Li‐Tzong Chen, Chun‐Mao Lin, et al.. (2012). Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator. Journal of Clinical Pathology. 65(4). 309–314. 15 indexed citations

16.

Li, Chien‐Feng, Ju-Ming Wang, Hong‐Yo Kang, et al.. (2012). Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics. Clinical Cancer Research. 18(6). 1598–1610. 39 indexed citations

17.

Tsai, Jen-Wei, Chien‐Feng Li, Yu‐Chien Kao, et al.. (2012). Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator. Annals of Surgical Oncology. 19(8). 2716–2725. 21 indexed citations

18.

Li, Chien‐Feng, Ju-Ming Wang, Ching‐Cherng Tzeng, et al.. (2011). EGFR Nuclear Import in Gallbladder Carcinoma: Nuclear Phosphorylated EGFR Upregulates iNOS Expression and Confers Independent Prognostic Impact. Annals of Surgical Oncology. 19(2). 443–454. 23 indexed citations

19.

Huang, Hsuan-Ying, Shau-Hsuan Li, Shih-Chen Yu, et al.. (2009). Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 15(22). 6963–6972. 41 indexed citations

20.

Zhao, Lei, Xunde Xian, Wei Huang, et al.. (2009). A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients. Clinical Chemistry and Laboratory Medicine (CCLM). 47(9). 1067–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact